ArticleAntibodies (Basel, Switzerland)2024

Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1.

Julia Harwardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.